Category survey

Genetic Correction of Mutant Huntingtin in Vivo Investments > €500k United States of America Huntington’s disease 2016    

TAM receptor control of microglial function and nervous system homeostasis Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Role of the IL-13 system in dopaminergic cell death Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Modeling Parkinsons Disease with Isogenic hiPSC-Derived Dopaminergic Neurons Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Neuron- and Circuit-Specific Mechanisms and Adaptations Regulating Motor Function in Parkinson Disease Models Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Mouse model studies of TMEM230-linked Parkinsons disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Neurofilaments, SOD1 and Motor Neuron Diseases Investments > €500k United States of America Motor neurone diseases 2016    

Environmental Metals, Excitotoxicity and ALS Investments > €500k United States of America Motor neurone diseases 2016    

An In Vitro Model of Stem Cell Innervation of Myotubes Investments > €500k United States of America Motor neurone diseases 2016    

Immune Regulation of Neuronal Injury and Repair Investments > €500k United States of America Motor neurone diseases 2016    

Induced Adult Neurogenesis for Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Scaling and Sequencing Motor Output in Humans: fMRI Study Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Deconstructing the cellular and molecular basis of SBMA motor neuron disease: From mechanism to therapy Investments > €500k United States of America Spinal muscular atrophy (SMA) 2016    

The Clinical Profile of Parkinsons Disease (PD) Pathology Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Mechanisms controlling skeletal muscle mitochondrial function and metabolic health Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

LRRK2, KIF5A and Parkinson disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Regulation of glutamate transport in astrocyte subtypes and in ALS Investments > €500k United States of America Motor neurone diseases 2016    

AMPK, metabolism and ALS Investments > €500k United States of America Motor neurone diseases 2016    

Developmental Factors for Reducing Dopamine Loss in Primate Models of PD & Aging Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Molecular Chaperones and Small Molecules Investments > €500k United States of America Huntington’s disease 2016    

White Matter Connectivity and PD Cognitive Phenotypes Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Dopaminergic and Muscarinic Signaling in the Striatum Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

C9ORF72 in Motor System Biology and ALS Investments > €500k United States of America Motor neurone diseases 2016    

Mechanism of DNA strand-break repair deficiency in Huntingtons disease Investments > €500k United States of America Huntington’s disease 2016    

The PPAR-delta pathway in neural function and Huntingtons disease neuropathology Investments > €500k United States of America Huntington’s disease 2016    

Temporal Patterns of Deep Brain Stimulation Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Transgenic marmosets for translational stem cell research Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Association of ALS to gene-environment mediated changes in HDL proteins Investments > €500k United States of America Motor neurone diseases 2016    

Chronic physiologic and behavior changes induced by novel STN DBS patterns for PD Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Chronic physiologic and behavior changes induced by novel STN DBS patterns for PD Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Peptide Biomarkers for Parkinson Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Spatiotemporal optimization of deep brain stimulation for Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Analysis and characterization of a cohort of familial Parkinsons disease exomes Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Methods for Dynamic Causal Interactions in Human Brain Function and Dysfunction Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back Investments > €500k United States of America Motor neurone diseases 2016    

Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

The Pathophysiology of Network Synchrony in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Investigation of ALS caused by mutant CHCHD10 Investments > €500k United States of America Motor neurone diseases 2016    

Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian Monkey Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Biomarkers for early intervention in Parkinson disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Molecular Genetic Characterization of SCA8 Investments > €500k United States of America Spinocerebellar ataxia (SCA) 2016    

The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

A Longitudinal Analysis Stream for FreeSurfer Investments > €500k United States of America Neurodegenerative disease in general 2016    

Dopaminergic encoding of counterfactual information in human striatum Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Nortriptyline-mediated attenuation of alpha-synuclein pathology in Parkinsons disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

LRRK in Autophagy Function and Dopaminergic Neuron Survival Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Neurodegeneration and Brain Function in Aging with HIV and Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Protein Aggregation and Inclusion Body Formation Investments > €500k United States of America Huntington’s disease 2016    

Growth and Development of the Striatum in Huntingtons Disease Investments > €500k United States of America Huntington’s disease 2016